Found 9 matching trials
Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
PHASE1The purpose of this study is to evaluate if TD-4208, an investigational dru...
Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
PHASE1This multiple-center, nonrandomized, open label, parallel group, single dos...
Location
Orlando Clinical Research Center (OCRD)
A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
PHASE2This study evaluated the safety and efficacy of four doses of TD-4208 and a...
Location
Upstate Pharmaceutical Research
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
PHASE3The purpose of this study is to measure the safety and tolerability of TD 4...
Location
Palmetto Medical Research Associates L.L.C
A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
PHASE2This study evaluated the safety and efficacy of once and twice daily TD-420...
Location
American Health Research
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
PHASE3The purpose of this study is to measure the effectiveness and safety of TD ...
Location
Palmetto Medical Research Associates L.L.C.
Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment
PHASE1This multiple-center, nonrandomized, open label, parallel group, single dos...
Location
Orlando Clinical Research Center (OCRC)
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
PHASE3The purpose of this study is to measure the effectiveness and safety of TD ...
Location
Allergy Associates Research Center (AARC)
Phase 4 COPD and Suboptimal Inspiratory Flow Rate
PHASE4Study is a randomized, double-blind, double-dummy, parallel-group study eva...
Location
Theravance Biopharma Investigational Site